Placebo-controlled study in neuromyelitis optica—Ethical and design considerationsBruce Cree, Eliezer Katz, Hans-Peter Hartung et al.|Multiple Sclerosis Journal|2015Cited by 72
Challenges and opportunities in designing clinical trials for neuromyelitis opticaBrian G. Weinshenker, Michael R. Yeaman, Gerard Barron et al.|Neurology|2015Cited by 46